Brookline, MA, United States of America

Mark Umbarger

This inventor holds 27 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Genetic Screening. Top assignees: Good Start Genetics, Inc., Molecular Loop Biosciences, Inc., Molecular Loop Biosolutions, LLC. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Umbarger. Retrieved from https://idiyas.com/inventor/mark-umbarger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 163(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Copy Number Determination
Genetic Screening
Single-Nucleotide Polymorphisms
Quality Control
Genetic Markers
Multiplex Sequencing
Nucleic Acid Analysis
Structural Variants
Carrier Status
Barcoding
Capture Reactions
Genomic Regions
27 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Mark Umbarger

Introduction: Mark Umbarger, based in Brookline, MA, is a prolific inventor known for his significant contributions to the field of genetics and molecular biology. With a commendable portfolio of 25 patents, Mark's work focuses on enhancing the reliability and efficiency of genetic analyses.

Latest Patents: Among his latest innovations, Mark has developed methods and compositions for evaluating genetic markers. This invention is designed to minimize bias and improve the reproducibility of multiplex analyses of genetic loci. It utilizes predetermined preparative steps and advanced nucleic acid sequence analysis techniques for multiple genetic loci across various samples. Another noteworthy patent pertains to capture reactions, which outlines methods to conduct a capture reaction. This process involves acquiring a nucleic acid, fragmenting it, and capturing a target sequence on the nucleic acid fragment using capture moieties, such as molecular inversion probes.

Career Highlights: Mark has played pivotal roles in leading biotechnology companies, consistently pushing the boundaries of genetic research. He has worked with reputable organizations such as Good Start Genetics, Inc. and Molecular Loop Biosciences, Inc., where he contributed to innovative solutions in genetic testing and molecular diagnostics.

Collaborations: Throughout his career, Mark has collaborated with esteemed colleagues in the field, including Gregory J. Porreca and George M. Church. These partnerships have enriched his research endeavors and fostered advancements in the genetic evaluation landscape.

Conclusion: Mark Umbarger stands out as a notable figure in genetic research, with a robust portfolio of patents and collaborations that demonstrate his commitment to innovation. His latest inventions continue to shape the future of genetic analysis, ensuring more reliable and reproducible results in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…